With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

Often symptomless, fatty liver disease is becoming a leading cause of liver cancer. Learn the role of daily habits, early ...

Men with cirrhosis have a significantly higher risk for liver-related complications ― particularly hepatocellular carcinoma ― than women, with more pronounced sex differences in nonviral ...

Use of sodium-glucose cotransporter 2 inhibitors was linked to significantly reduced risk for serious liver events for patients with cirrhosis treated with furosemide and spironolactone, according ...